Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Stiefel
Stockley Park West, , Uxbridge, Middlesex, UB11 1BT , UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 27/01/2011
SPC Warticon Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27/01/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   22-Jan-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


7.

GlaxoSmithKline UK Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS

Trading as Stiefel
Stockley Park West
Uxbridge
Middlesex
UB11 1BT

 

8.

PL 19494/0074

10.

22 January 2011
Updated on 21/08/2009 and displayed until 27/01/2011
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   17-Aug-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 7: Update to the address of the MAH

Section 10: Date updated 
Updated on 26/11/2008 and displayed until 21/08/2009
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 4.1 - Therapeutic indications
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Nov-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


Warticon Solution was previously marketed in two formats: Warticon for male patients and Warticon FEM for female patients.  The formulations were identical.  The Warticon FEM pack has been discontinued and Warticon will be used for both indications going forward.  The SmPC has been amended to delete references to Warticon FEM and to include both male and female indications for Warticon.

 
Updated on 27/09/2005 and displayed until 26/11/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 22/08/2001 and displayed until 27/09/2005
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
  podophyllotoxin